Journal
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
Volume 18, Issue 2, Pages 186-192Publisher
SPRINGER JAPAN KK
DOI: 10.1007/s10147-013-0526-9
Keywords
Endometrial cancer; MicroRNA; Epigenetic; miR-152; miR-34b
Categories
Funding
- Japan Society for the Promotion of Science (JSPS) [22390313, 22591866, 24791718]
- Ichiro Kanehara Foundation
- Kobayashi Foundation for Cancer Research
- Keio University
- Grants-in-Aid for Scientific Research [25462608, 22390313, 22591867, 22591866, 24791718] Funding Source: KAKEN
Ask authors/readers for more resources
MicroRNAs (miRNAs) are small non-coding ribonucleic acids (RNAs) of approximately 22 bp that induce RNA interference with a complementary messenger RNA (mRNA) and act in silencing of mRNA. miRNAs are strongly associated with cancer development and those involved in carcinogenesis are classified into oncogenic miRNAs and tumor suppressor miRNAs (tumor suppressor miRs). Specific miRNAs are expressed in various tissues and changes in regulation of gene expression are thought to cause carcinogenesis. Thus, tissue-specific miRNAs may be biomarkers for cancer diagnosis and prognosis. Approaches to application of miRNAs as cancer therapy are also ongoing, based on the involvement of miRNAs in carcinogenesis. In endometrial cancer, miRNAs are associated with regulation of gene expression, epigenetic dysfunction and carcinogenesis. Thus, miRNAs are likely to have key roles in diagnosis, prognostic prediction, and therapy in endometrial cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available